Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 49, Issue 2, Pages 718-721Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01773-10
Keywords
-
Categories
Funding
- INSERM [U914]
- Ministere de l'Education Nationale et de la Recherche, Universite Paris XI, Paris, France [UPRES-EA3539]
- European Community [HEALTH-2009-241742]
Ask authors/readers for more resources
Enterobacterial isolates expressing the carbapenemase NDM-1 are emerging worldwide. Twenty-seven NDM-1-positive isolates of worldwide origin were included in this study to identify these strains as not only pathogens but also colonizers of normal flora for infection control screening. Although susceptibility to carbapenems varied, a combined test (IMP/IMP + EDTA), the Etest MBL, and automated susceptibility testing by Vitek2 (bioMerieux) identified those NDM-1 producers as verified by PCR using specific primers. Screening for carriers of NDM-1 producers may be based on media such as the ChromID ESBL culture medium routinely used to screen for extended-spectrum beta-lactamase producers, which gives excellent detection levels with low limits of detection ranging from 8 x 10(0) to 5 x 10(2) CFU/ml. The CHROMagar KPC culture medium had higher limits of detection (1 x 10(1) to 5 x 10(5) CFU/ml) and may be proposed for the follow-up of outbreaks of infections with NDM-1 producers. Colonies growing on these screening media can be verified as NDM-1 producers with molecular methods as described herein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available